Looking for a specific product?

Make a search for products & suppliers, articles & news.

Bionor Pharma Positioned for Execution of the Kick, the Kill and the Boost Strategy, Aiming Towards a Functional Cure for HIV

Bionor Pharma ASA (OSE: BIONOR) announced today results from the third quarter and first nine months of 2013. 

The Q3 report will be presented by webcast 8 November at 8.30 am CET. Link for registration and access to the webcast: http://www.media-server.com/m/p/zovaz8yn
See further information about the webcast and call numbers below.

Download the Q3 report and Q3 presentation.

 

If you would like to find out more about Bionor Pharma, please visit their website here.

Associated companies:


Related news

Latest news

PRESS RELEASE: Servogear to propel Asian built windfarm vessels

The contract with Cheoy Lee Shipyards was signed in Q2 2018.

SERVICEBULLETIN: Grease filling of the propeller system

SERVICEBULLETIN 180921: Grease filling of the propeller system

FILM: The world´s first HD220 gearbox returns for an overhauling

The gearbox has been operating flawlessly for more than 20.000 hours...

Øveraasen delivers machine number 66 to New York

Totally over the last ten years, 

DNV GL commission worlds largest industrial explosion chamber at Spadeadam Research and Testing

The chamber supports not only a joint industry project ...

DNV GL celebrates double win at Lloyd’s List Asia Pacific Awards

We would like to thank all of the judges and Lloyd’s List for these awards,

WITH OR WITHOUT SKIRTINGS?

A theme that often comes back to me while working with new customers is the flooring,

Heating cable segment officially transferred to ØS Varme

Øglænd System AS’s future strategy will be focused on the sale...

Genesis is celebrating its 30th anniversary

TechnipFMC’s market-leading engineering and advisory company,